why choose us

First received: March 03, 2023

Clinical Trial: Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta

Study Status: Completed

Recruit Status: RECRUITING

Condition: Osteogenesis Imperfecta

Study Type: INTERVENTIONAL


Official Title: An Open-label, Randomized, Active-Controlled, Phase 3 Study of Setrusumab Compared With Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta Types I, III or IV

Brief Summary: The primary objective of the study is to evaluate the effect of setrusumab vs intravenous bisphosphonates (IV-BP) on reduction in fracture rate, including morphometric vertebral fractures in pediatric participants.

Read more